4 groups: 1) a group with a negative LDCT result, which was excluded from further follow-up; 2) a group with nodules of less than 5 mm in size, which had 1 follow-up visit after 12 months; 3) a group with nodules between 5 and 10 mm in size, which had follow-up visits 3, 6, and 12 months after the first LDCT; and 4) a group with nodules exceeding 10 mm in size, who were referred for further diagnostic workup. The number, diameter, size, consistency, presence of air, shape, and edge pattern of nodules as well as the presence of calcification and additional findings were recorded in the form available on the program's website by each radiologist and consultant.
All positive results were reviewed by 3 consultants (2 radiologists and 1 thoracic surgeon) who decided whether further screening was needed. The results were entered into a web-based form and collected in a central database. The results were provided to participants in the radiological center in which the study was performed with detailed guidelines. All patients who were subject to screening were suggested to undergo additional LDCT screening every 12 to 15 months on their own.
The diagnostic workup in patients with nodules greater than 10 mm in size was performed in the Department of Thoracic Surgery of the Medical University of Gdańsk, and the workup consisted of spirometric tests, exertion tests, bronchoscopy or autofluorescence bronchoscopy, and fine-needle aspiration biopsy. 8,9 All patients referred for surgery underwent surgery in the same institution. The study flowchart is presented in Additional projects A total of 1596 health care professionals (915 family doctors, 55 radiologists, and 626 family nurses) from the Pomerania region were educated about lung cancer diagnosis and treatment as well as lung cancer screening in a series of 18 training sessions.
In 3373 program participants, blood was collected for further molecular studies 10 after participants provided written informed consent.
In 724 participants, pilot cardiovascular screening was performed on the basis of the same definition of the high-risk group. In all participants, primary cardiovascular risk factors were assessed. This issue will be presented in a separate publication.
ResUlTs In 8649 healthy volunteers (median age, 60.6 years) who underwent LDCT screening, 13 978 computed tomography examinations were performed. In total, 3004 of 8649 individuals (34.7%) underwent more than 1 round of LDCT screening. Men and women constituted 52% and 48% of the patient cohort, respectively. In addition, the cohort included 68% of current and 32% of former smokers who had a mean smoking history of 35 pack-years (range, 0-200 pack-years).
Lung nodules were detected in 4694 individuals (54%), most commonly as a single nodule So far, 10 randomized and 18 observational LDCT screening studies regarding lung cancer have been published. 5, 6 it has been estimated that 180 000 individuals are potentially in the high-risk group as described below. The aim of the study, in addition to investigating screening using LDCT, was to educate regional medical staff (family doctors, family nurses, and radiologists) about lung cancer diagnosis, treatment, and screening to build a lung cancer diagnostic and therapeutic network in Pomerania for potential use in future studies.
Participants
The program included healthy asymptomatic current or former smokers aged between 50 and 75 years with a smoking history of at least 20 pack-years. Among individuals with a family history of smoking, the minimum smoking history was 10 pack-years. The number of recruited participants was determined by the program's budget.
Recruitment methods Participants were recruited via a website and infolines during the first week and via infolines, family doctors, and nurses thereafter. Website recruitment was discontinued owing to an overwhelming interest (over 2000 registrations within the first 4 days). Participants were also recruited via television, radio, and newspaper advertisements as well as via an informational campaign involving educated family doctors and nurses.
low-dose computed tomography LDCT was performed in 19 radiological centers in Pomerania. All radiologists were educated about the study protocol and reading LDCT scans to evaluate the features of nodules. The I-ELCAP radiological protocol was applied with regards to the equipment requirements and methodology.
screening The screening protocol was designed for a 1-year follow-up due to the programs' time frames. Individuals were categorized into 1 of without previous diagnostic workup owing to a difficult localization of the lesion. Lung cancer was diagnosed in 107 patients (1.24%), 78 of whom (72.9%) were diagnosed after the first round of screening. The majority of subjects with lung cancer (66.4%) had stage I or II cancer according to the 7th edition of the TNM classification. Eighty-one patients (75.7%) underwent surgery with a curative intent, and 26 patients received oncological treatment. There were no deaths in the surgical group, and the rate of complications was as low as 15%. Adenocarcinoma (including bronchoalveolar carcinoma) was the most common finding on histology (63.6%) followed by squamous cell carcinoma (22.4%). The majority of surgical patients underwent lobectomy (video--assisted, in 30 patients; open, in 38 patients). Three patients (2 in pathological stage IIIA and 1 in stage IIB) underwent pneumonectomy. The mean length of hospital stay was 8 days (range, 5-48 days). Stage I NSCLC was detected in 64 of the surgical patients (79.0%). There were 24 futile thoracotomies (54.5%) among 44 surgeries for nonmalignant lesions. Nine patients had tuberculomas; three, mediastinal tumor; and one, neurofibroma, in which surgery is recommended (TABle 2) . The most common findings in the benign group were tuberculoma (20.5%) and local fibrotic or atelectatic changes (39.2%) with a diameter of less than 10 mm (92%) (FIGURe 2).
Among the 2116 additional findings, mediastinal lymph node enlargement was the most common (755 cases, 35.6%).
A similar nodule size was recorded in 4512 follow-up CT examinations (84.6%), while an increase or decrease in size was observed in 619 examinations (11.6%) and 198 examinations (3.7%), respectively. In 581 of 10 290 consulted examinations (5.64%), the nodule estimation results were incongruent between consultants and radiologists.
A diagnostic workup was performed in 300 individuals. In 227 cases (75%), the workup was done after the first screening round. Transthoracic fine-needle aspiration biopsy was successful in 44 of 82 patients (61%) with lung cancer who were diagnosed by LDCT. In the remaining 37 cases, surgery was performed on the basis of radiological criteria of malignancy. Complications such as pneumothorax (42%) and lung hematoma (7%) occurred in 49 of 233 (21.0%) of diagnosed individuals, 17 of whom (7.3%) required chest-tube drainage. The number and type of diagnostic procedures are listed in (31.8%). There were no deaths in the nonmalignant group, and the complication rate was 11%. The characteristics of the surgical patients are shown in TABles 2 and 3. Most of the participants remain under observation outside the program. A total of 254 deaths (2.94%) were recorded until November 2013 in the study cohort: 129 (50.8%) were cancer-related, 67 (26.4%) were due to cardiovascular causes, and 60 (22.8%)-due to other reasons.
DIsCUssION
The detection rates of 54% via LDCT screening in this study and of 32% of cases proposed as a screening tool, and the results of several studies have been inconsistent. 1,6 The National Lung Screening Trial, which reported a reduction in mortality greater by 20% in the LDCT screening arm than in the chest X-ray arm, changed the landscape of lung cancer screening 5 by shifting the focus from "whether" screening should be performed to "how" screening should be performed and implemented. The era of studies focused on specific questions in the fields of radiological assessment, indications, organizational aspects, and other practical issues related to lung cancer screening using LDCT has arrived.
Our "open-access" observational study covered the region of Pomerania in northern Poland to simulate a potential application of LDCT screening. The study comprised 19 radiology centers that were evenly spread across the voivodeship, and thus, accessibility was similar for the entire population. The number of follow-up LDCTs was limited only to a 12-month period owing to time restrictions forced by the program. However, most of the volunteers are under observation outside the program. We practically educated a significant number of health care employees in the region about lung cancer diagnosis and treatment as well as LDCT screening principles. This, together with the experience of the radiologists involved in the program will provide an excellent network for further studies, and, in our opinion, the development of this network represents one of the most useful results of the program. We have tested the "centralized" pattern of screening design with 1 institution having a full control over the examinations, analysis of patient findings, and subsequent diagnosis and treatment (TABle 5) . When the family doctor is not directly involved in referring a smoker for such a screening, all responsibility concerning the explanation of positive computed tomography results must be provided by the team. In our opinion, the major drawbacks in our program design was the lack of psychologists and smoking cessation program in the outpatient setting.
Open-access protocols without the involvement of general practitioners have been used in other studies 13, 17, 26, 27 and resulted in better recruitment than that observed in the studies involving general practitioners. [18] [19] [20] 28, 29 The interest of participants was enormous, as underlined by the more than 2000 registrations on the program website during the first 4 days of enrollment. For practical reasons and time constraints, we were forced to discontinue website recruitment. These findings indicate that problems with recruitment in previous breast and cervical cancer programs in Poland were not applicable to LDCT screening. However, this form of recruitment has important drawbacks. We observed that a substantial proportion of volunteers overstated their smoking histories to be accepted in the study. Two never-smoking women with a pulmonary nodule (1 tuberculoma and 1 NSCLC) underwent surgery. Internet blogs provided instructions on referred for secondary screening are higher than those reported previously (ranging from 1.6% to 53%). 11, 12 This results from the fact that our protocol defined every found nodule as positive irrespective of a radiological analysis. By using our experience, we could substantially reduce the number of positive results that required further follow-up. This same factor will also reduce unnecessary diagnostic workup, which was higher in our study than in previous studies, 12-16 mainly because diagnostic procedures were performed in our study for nodules larger than 10 mm in diameter instead of 15 mm, as performed in some other studies. 13, [17] [18] [19] [20] [21] [22] The lung cancer detection rate of 1.24% in this study is in line with most published data 11, 13, 14, 16, 20, 23 (TABle 4) .
The proportion of stage I and II cancers was much higher (66.4%) than that observed in general practice but lower than that reported by Henschke et al.,
4,15 whose cohort consisted primarily of individuals with stage I NSCLC (85%). A careful recruitment of each volunteer by health care employees is necessary to obtain such a result. One-fourth of the surgical patients underwent futile thoracotomies.
24 This number should definitely be reduced, although it does not differ substantially from that observed in our daily practice. During this same period, 20% of patients with nonmalignant lesions underwent surgery in our department, outside the screening program.
Lung cancer screening has evolved slowly since 1966 when Lilienfeld et al.
25 published their series of 14 607 volunteers who underwent chest X-ray and sputum examinations to detect the presence of lung cancer. Since 1992, LDCT has been how to effectively apply for the study. In total, 1020 volunteers (12%) reported a smoking history of exactly 20 pack-years, and, potentially, most of the "biased" participants are included in this group. Additionally, a higher proportion of stage III and IV lung cancers was detected in our study (33.6%) in comparison with other studies because some individuals hid symptoms that would have been discovered in a careful case history evaluation. The detection rate of lung cancer in LDCT screening appears to be low considering the overall morbidity of patients with this malignancy. Conversely, when compared to cervix cancer or breast cancer screening, its effectiveness is at least as good. Nevertheless, it is obvious that other tests should be developed to better define the high-risk group for lung cancer. This appears to be the only means of enhancing the effectiveness of LDCT screening and its economical value, which will result in a broad application of this screening method.
